Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 3)

v3.20.2
Stockholders' Equity (Details 3) - Warrant [Member]
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Warrants, Outstanding  
Beginning Balance | shares 4,907,223
Granted | shares 12,120,000
Exercised | shares (20,000)
Cancelled | shares
Ending Balance | shares 17,007,223
Warrants, Exercisable  
Beginning Balance | shares 4,907,223
Granted | shares
Exercised | shares
Cancelled | shares
Ending Balance | shares 15,495,973
Weighted Average, Exercise Price, Outstanding  
Beginning Balance $ 2.40
Granted
Cancelled
Exercised
Ending Balance 1.65
Weighted Average, Exercise Price, Exercisable  
Beginning Balance 2.40
Granted
Exercised
Cancelled
Ending Balance 1.61
Weighted Average, Fair Value Vested  
Beginning Balance 1.11
Granted
Exercised
Cancelled
Ending Balance $ 0.78
Weighted Average, Contractual Life (Years)  
Beginning Balance 1 year 6 months 18 days
Ending Balance 4 years 1 month 16 days
Aggregate Intrinsic Value  
Beginning Balance | $
Granted | $
Exercised | $
Cancelled | $
Ending Balance | $ $ 549,982